Biomarkers Industry Is Estimated To Move Ahead At A Cagr Of 14.20% During 2023 To 2030
Biomarkers Industry Data Book Covers Cardiac & Cancer Biomarkers, Non-alcoholic Steatohepatitis Biomarkers, Global Neurological Biomarkers Markets. The global biomarkers markets combine to account for USD 41.62 billion revenue in 2021, which is expected to reach USD 137.76 billion by 2030, growing at a cumulative rate of 14.2% over the forecast period . Cardiac Biomarkers Market Report Highlights The global cardiac biomarkers market size was valued at USD 13.98 billion in 2021 and it is expected to reach USD 47.88 billion by 2030. It is expected to expand at a CAGR of 14.7% from 2022 to 2030. By type, the troponin segment held the largest revenue share in 2021 owing to its high usage in cardiovascular diseases diagnosis Based on application, the acute coronary syndrome segment is expected to grow at a lucrative rate during the forecast period due to the increasing prevalence of coronary diseases and expanding applications of these biomarkers in the di...